Gender Dysphoria, Gender Identity, and Related Conditions – Detailed Study Notes

Page 1

Key Terms and Diagnostic Nomenclature

  • Gender identity – the internal sense of being male, female, or another gender; usually aligns with one’s anatomical sex.

  • Gender dysphoria (GD) – marked incongruence between experienced/expressed gender and gender assigned at birth, accompanied by clinically significant distress or impairment; first appeared in DSM\text{-}5.

  • Previous terminology: Gender Identity Disorder (GID) in DSM\text{-}IV.

  • ICD-10 groups gender identity concerns under “Disorders of Adult Behaviour and Personality” with five codes:

    1. Transsexualism

    2. Dual-role transvestism

    3. Gender identity disorder of childhood

    4. Other gender identity disorders

    5. Gender identity disorder, unspecified

  • ICD Working Group (toward ICD-11) is debating relocation of these diagnoses to a new sexual-health chapter, to reduce pathologisation.

  • Transgender (TG) – umbrella term for anyone whose gender identity differs from their birth-assigned gender.

Significance

Moving GD away from “mental disorder” sections (as proposed for ICD\text{-}11) may reduce stigma, improve access to care, and align with human-rights frameworks.

Page 2

Diversity within the Transgender Spectrum

  • Transsexuals – seek to alter their bodies to resemble their identified gender.

  • Genderqueer / Non-binary – identify between, both, or outside male/female categories.

  • Cross-dressers – wear clothing of another gender while retaining birth-assigned gender identity.

Surgery & Orientation Myths

  • The majority of TG people do not undergo genital surgery – reasons include lack of desire or financial barriers.

  • Gender identity and sexual orientation are independent – e.g., a transgender man (assigned female at birth) may be gay, straight, or bisexual.

DSM-5: Diagnostic Focus in Children

  • Core criterion: persistent desire to be another gender or insistence that one is another gender.

  • Emphasises the child’s self-report, protecting merely gender-nonconforming children from pathologisation.

  • Typical behavioural markers:

    • Preference for clothing, toys, roles, and playmates of another gender.

    • Dislike of own anatomy, desire for anatomy/secondary characteristics of another gender.

    • Statements about changing genitals or urinating in another-gender style.

  • Diagnosis requires the child (not caregivers) to experience distress/impairment.

Page 3

DSM-5: Adolescents & Adults

  • Must display gender incongruence plus ≥2 of 6 criteria, \geq6-month duration, and personal distress/impairment.

  • Criteria include desire to eliminate own sex characteristics, desire for other-gender characteristics, desire to be or be treated as another gender, or conviction of having typical feelings/reactions of another gender.

  • DSM-5 explicitly allows non-binary identities.

  • Post-transition specifier – for individuals living in affirmed gender after ≥1 medical/surgical step or while preparing for one.

Clinical Practice Notes

  • Many clients seek letters supporting hormones or surgery.

  • “Trapped in the wrong body” narrative is not universal; clinicians should use affirming, patient-led language.

Page 4

Table 17-1 Highlights – DSM-5 vs. ICD-10

  • Duration: ≥6 months (DSM-5); variable in ICD.

  • Symptom clusters

    • Children: \geq 6 of 8 indicators (see page 4 list).

    • Adults: \geq 2 of 6 indicators.

  • ICD-10 Subtypes – Transsexualism, Dual-role transvestism, GID of childhood, etc.

  • Exclusions – Not better explained by sexual arousal (i.e., transvestic disorder), tomboyishness, ego-dystonic sexual orientation, or sexual maturation disorder.

  • Specifiers – “With disorder of sex development” (DSD) and “Post-transition.”

Page 5

Additional Diagnostic Nuances

  • Children need ≥6 indicators; adults need ≥2.

  • Motivation must not be sexual arousal.

  • Functional impairment or clinically significant distress is required.

Page 6

“Other Specified” & “Unspecified” GD

  • Used when distress is present but full criteria are not met. Clinician must (or may) state reason.

Case Example (Female-to-Male, FtM)

  • 27-year-old AFAB (assigned female at birth).

  • Lifelong discomfort with femininity; concealed breasts, distress over menses.

  • Sexually attracted to women yet did not identify as lesbian; self-concept: man.

  • Accessed online FtM support, transitioned socially, began androgen therapy.

  • Changes: voice deepening, facial/body hair, amenorrhoea, increased libido, clitoral hypertrophy.

  • Surgical steps: bilateral mastectomy; wait-listed for phalloplasty & hysterectomy/oophorectomy.

  • Maintains employment and 3-year relationship with female partner who has a child.

Page 7

Differential Diagnosis – Children

  • Key discriminator: persistent desire for anatomic change.

  • Non-persisting gender-nonconforming behaviours alone ≠ GD.

  • Intersex (DSD) no longer excluded; coded with specifier.

  • Historical note: early genital surgeries on intersex infants caused harm (e.g., sterility), prompting modern deferment of surgery until patient consent.

Differential – Adolescents & Adults

  • GD requires distress; non-distressed TG individuals not diagnosed.

  • Rarely, gender content may appear in psychotic delusions (e.g., schizophrenia) – resolves with antipsychotics, unlike GD.

  • Body Dysmorphic Disorder (BDD) – fixation on perceived abnormality, not gender.

  • Transvestic Disorder – sexual arousal from cross-dressing; gender identity aligns with birth-assigned sex.

Page 8

Developmental Course & Prognosis

  • Sense of gender identity forms ≈3 years.

  • School age: clinical referrals rise as social scrutiny increases.

  • Puberty: distress often escalates due to impending secondary sex traits.

  • Long-term follow-up: >50\% of GD-diagnosed children later identify with birth-assigned gender; persistence correlates with severity of childhood GD.

  • Childhood gender nonconformity predicts higher rates of gay/bisexual adulthood.

Page 9

Comorbidity

  • Children: Elevated rates of depressive, anxiety, impulse-control disorders; higher prevalence of autism spectrum traits.

  • Adults: Increased depression, anxiety, substance use, self-harm; lifetime suicidal ideation ≈40\%.

    • Minority Stress Model explains elevated morbidity in stigmatised groups.

  • Late-onset GD may have fluctuating distress and less satisfaction post-surgery.

Page 10

Treatment – Ethical Framework

  • Affirmative, exploratory therapy is standard.

  • Reparative/Conversion therapy targeting gender identity is unethical (condemned by APA, AACAP).

Children

  • Individual, family, and group therapy to explore identity & support.

Adolescents

  • If intense distress at puberty onset → consider GnRH agonists (puberty blockers).

    • Provide reversible pause, letting youth decide on future steps.

    • Safety profile established from use in precocious puberty.

Adults

  • Multi-modal care: psychotherapy, hormone therapy, surgery.

  • Evidence: hormone/surgical interventions ↓ depression & ↑ quality of life.

  • Historical gate-keeping (letters for hormones/surgery) waning; informed consent models increasing.

  • Guidance: WPATH Standards of Care v7 promotes flexibility & patient autonomy.

Page 11

Hormone Therapy – Transgender Men (TGM)

  • Agent: Injectable testosterone weekly/bi-weekly.

  • Early changes: acne, muscle mass ↑, libido ↑, menses stop (within months).

  • Later & largely irreversible: voice deepening, body hair ↑, clitoral growth.

  • Monitoring: hemoglobin/hematocrit (polycythaemia risk), liver function, lipids, diabetes screening.

  • Fertility: potential reduction; counsel on gamete preservation before initiation.

Hormone Therapy – Transgender Women (TGW)

  • Regimen: Estrogen + androgen blockers (e.g., spironolactone) ± progesterone.

  • Changes: skin softening, fat redistribution, breast growth (up to cup B), ↓ libido, ↓ erections/ejaculation, modest body-hair ↓.

  • Voice: no change; many seek voice therapy.

  • Risks & Monitoring: avoid smoking (thrombosis risk), check BP, liver enzymes, lipids, and prolactin (rare prolactinoma).

  • Fertility: near-certain sterility; pre-treatment sperm banking advised.

Page 12

Surgical Interventions

  • Chest (“Top”) Surgery – most common for both:

    • TGM: bilateral mastectomy & chest contouring.

    • TGW: breast augmentation (post 18$–24 months hormones).

  • Genital (“Bottom”) Surgery

    • TGM Options

    • Metoidioplasty – frees hypertrophied clitoris; may enlarge with grafts.

    • Scrotoplasty – testicular implants.

    • Phalloplasty – multi-stage, flap-based penile construction; costly, variable function.

    • TGW Options

    • Vaginoplasty (Sex Reassignment Surgery, SRS) – orchidectomy + penile inversion/neovagina, creation of neoclitoris.

    • Orchidectomy alone – inexpensive androgen reduction.

    • Facial Feminisation Surgery (FFS) – reshapes bone/soft tissue for feminine cues; critical for safety & social integration.

  • Barriers: Cost, access, satisfaction uncertainty.

  • Risks of Unsafe Practices: self-surgery, illicit silicone injections → infection, emboli, death.

Page 13

Epidemiology – Children

  • Parents often notice cross-gender behaviour before 3 years.

  • In clinically referred youngsters (<12 yrs):

    • Desire to be other sex reported in 10\% of boys, 5\% of girls.

  • Sex ratio in referrals: 4$–5 boys : 1 girl; equalises in adolescence.

  • Many gender-nonconforming children do not become TG adults; conversely, many TG adults were not flagged in childhood.

Epidemiology – Adults

  • European clinic prevalence: \tfrac{1}{11{,}000} for male-assigned, \tfrac{1}{30{,}000} for female-assigned.

  • DSM\text{-}5 estimates:

    • Male-assigned: 0.005$–0.014\%.

    • Female-assigned: 0.002$–0.003\%.

  • Clinical sex ratio: 3$–5 MTF : 1 FTM.

  • Hypothesis (population, non-clinical): up to 1 in 500 adults somewhere on TG spectrum.

Page 14

Etiology – Biological Factors

  • Default mammalian pathway is female; androgen surge (Y-chromosome driven) → testes → masculinisation.

  • Brain Organisation Theory: prenatal testosterone alters hypothalamic neurons; link to adult behaviour debated.

  • Genetics: twin studies show mixed concordance; no definitive genes yet.

  • Neuro-imaging: preliminary findings of differences in white-matter tracts, cerebral blood flow, activation patterns.

  • TG individuals show higher left-handedness; significance unknown.

Page 15

Etiology – Psychosocial Factors

  • Formation involves temperament × parental attitudes × cultural gender roles.

  • Psychoanalytic Views (Freud): disruptions in oedipal triad, maternal relationships, or separation-individuation may yield GD.

  • Hostile/devaluing mothering, absent/depressed mother, or absent father can affect identity formation.

  • Learning Theory: reinforcement/punishment of gendered behaviours shapes expression; children later grasp constancy of gender despite superficial cues.

Cultural Context & Stigma

  • Western societies increasingly accept gender-nonconformity, yet stigma persists (e.g., harsher toward “feminine” boys).

  • Understanding societal expectations and family dynamics is essential for ethical, effective care.

Page 16

Ethical, Practical, and Public-Health Implications

  • Depathologisation trends (ICD-11) aim to reduce social stigma and legal barriers.

  • High suicidality (~40\%) and violence risk necessitate accessible, affirming care.

  • Conversion therapy bans and informed-consent hormone protocols reflect evolving best practices.

  • Ongoing research on long-term effects of puberty blockade and cross-sex hormones will refine future guidelines.

Page 17 (References Overview)

List of key references cited (Adelson 2011; Carmel & Hopwood 2014; Devor 2004; Drescher 2009, 2012; Erickson-Schroth 2013; Grant et al. 2011$$; Green in Kaplan & Sadock). These works underpin diagnostic criteria evolution, minority stress research, and medical treatment protocols.